Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL702988 | 1.00 | MAPT (0.58) | MAPTKMT2AMEN1POLBCETP | |
| SCHEMBL7196887 | 0.86 | MAPT (0.55) | MAPTKMT2AMEN1POLBCETP | |
| SCHEMBL23515212 | 0.85 | CETP (0.52) | MAPTKMT2AMEN1POLBCETP | |
| SCHEMBL19766698 | 0.85 | MAPT (0.62) | MAPTKMT2AMEN1POLBCETP | |
| SCHEMBL11893003 | 0.83 | KMT2A (0.60) | MAPTKMT2AMEN1POLBSMN1; SMN2 | |
| SCHEMBL15414250 | 0.82 | ALOX5 (0.51) | KMT2AKDM4E | |
| SCHEMBL19610235 | 0.81 | MAPT (0.58) | MAPTKMT2AMEN1POLBCETP | |
| SCHEMBL5236602 | 0.81 | MAPT (0.58) | MAPTKMT2AMEN1POLBSMN1; SMN2 | |
| SCHEMBL4698919 | 0.81 | MAPT (0.58) | MAPTKMT2AMEN1POLBCETP | |
| SCHEMBL15798428 | 0.81 | MAPT (0.58) | MAPTKMT2AMEN1POLBCETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081133-A1 | MODIFIED POROUS WICKING MEMBRANES | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-04-21 | — | — | WO | disclosed |